Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectris Regulatory News (SXS)

Share Price Information for Spectris (SXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,330.00
Bid: 3,326.00
Ask: 3,330.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.12%)
Open: 3,410.00
High: 3,410.00
Low: 3,304.00
Prev. Close: 3,330.00
SXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

11 Mar 2024 12:33

RNS Number : 3726G
Spectris PLC
11 March 2024

Spectris plc: Director/PDMR Shareholding

This notification made under Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").

On 8 March 2024, Spectris plc (the "Company") was notified that on the same day, Derek Harding, Chief Financial Officer and Andrew Heath, Chief Executive, acquired 10,392 and 13,055 ordinary shares of 5p each ("Ordinary Shares") in the Company respectively following the exercise of options granted under the terms of the Performance Share Plan ("PSP") on 7 March 2019.

Of the 10,392 Ordinary Shares acquired by Mr Harding, 5,000 were sold to fund the option cost and the income tax / national insurance liability at a sale price of £33.452 and the remaining 5,392 Ordinary Shares were retained and immediately transferred into a nominee account on his behalf.

Of the 13,055 Ordinary Shares acquired by Mr Heath, 6,164 were sold to fund the option cost and the income tax / national insurance liability at a sale price of £33.465 and the remaining 6,891 Ordinary Shares were retained and immediately transferred into a nominee account on his behalf.

The forms for this transaction, as required under MAR, follows:

1

Details of the persons discharging managerial responsibilities

a)

Name(s)

Derek Harding, Chief Financial Officer

2

Reason for the notification

a)

Position/status

Director/PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Spectris plc

b)

LEI

213800Z4CO2CZO3M3T10

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 5p each

GB0003308607

b)

Nature of the transaction

(i) Exercise of options over 10,392 Ordinary Shares under the terms of the PSP granted on 7 March 2019.

(ii) Subsequent sale of 5,000 Ordinary Shares to cover option cost and income tax / national Insurance liabilities arising on exercise.

(iii) Transfer of remining 5,392 Ordinary Shares into a nominee account on Mr Harding's behalf.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

(i) Acquisition

£0.05

£0.00

£26.69

8,981 (Share Award granted as a nominal cost option under the terms of the PSP)

1,127 (Dividend equivalent shares awarded in lieu of dividend accrual on nominal cost option)

284 (Share Award granted as a tax-advantaged market value option under the terms of the PSP)

(ii) Sale

£33.452

5,000

(iii) Transfer

£nil

5,392

d)

Aggregated information

(i) Acquisition

Price per share

£0.7726

Volume

10,392

Price

£8,029.01

(ii) Sale

Price per share

£33.452

Volume

5,000

Price

£167,260.00

(iii) Transfer

Price per share

£0.00

Volume

5,392

Price

£0.00

e)

Date of the transaction

8 March 2024

f)

Place of the transaction

Outside of a trading venue

1

Details of the persons discharging managerial responsibilities

a)

Name(s)

Andrew Heath, Chief Executive

2

Reason for the notification

a)

Position/status

Director/PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Spectris plc

b)

LEI

213800Z4CO2CZO3M3T10

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 5p each

GB0003308607

b)

Nature of the transaction

(i) Exercise of options over 13,055 Ordinary Shares under the terms of the PSP granted on 7 March 2019.

(ii) Subsequent sale of 6,164 Ordinary Shares to cover option cost and income tax / national Insurance liabilities arising on exercise.

(iii) Transfer of remining 6,891 Ordinary Shares into a nominee account on Mr Heath's behalf.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

(i) Acquisition

£0.05

£0.00

11,608 (Share Award granted as a nominal cost option under the terms of the PSP)

1,447 (Dividend equivalent shares awarded in lieu of dividend accrual on nominal cost option)

(ii) Sale

£33.465

6,164

(iii) Transfer

£nil

6,891

d)

Aggregated information

(i) Acquisition

Price per share

£0.04446

Volume

13,055

Price

£580.40

(ii) Sale

Price per share

£33.465

Volume

6,164

Price

£206,278.26

(iii) Transfer

Price per share

£0.00

Volume (Shares Acquired)

6,891

Price (Shares Acquired)

£0.00

e)

Date of the transaction

8 March 2024

f)

Place of the transaction

Outside of a trading venue

Name of contact and telephone number for queries:

Guy Holden

Group Reward and Share Plan Manager

07585 403 180

For and on behalf of Spectris plc

LEI Number: 213800Z4CO2CZO3M3T10

Date: 11 March 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHGPUPWWUPCGPG
Date   Source Headline
9th Dec 20226:16 pmRNSTransaction in Own Shares
9th Dec 20227:00 amRNSTransaction in Own Shares
8th Dec 20222:21 pmRNSDirector/PDMR Shareholding
7th Dec 20225:32 pmRNSTransaction in Own Shares
6th Dec 20225:55 pmRNSTransaction in Own Shares
6th Dec 20227:00 amRNSTransaction in Own Shares
5th Dec 20227:00 amRNSTransaction in Own Shares
1st Dec 20225:59 pmRNSTransaction in Own Shares
1st Dec 202211:32 amRNSTotal Voting Rights
1st Dec 202211:18 amRNSVoting Rights and Capital
1st Dec 20227:00 amRNSTransaction in Own Shares
30th Nov 20227:00 amRNSTransaction in Own Shares
28th Nov 20226:23 pmRNSTransaction in Own Shares
25th Nov 20225:34 pmRNSTransaction in Own Shares
24th Nov 20226:31 pmRNSTransaction in Own Shares
24th Nov 20227:00 amRNSTransaction in Own Shares
22nd Nov 20225:51 pmRNSTransaction in Own Shares
22nd Nov 20221:58 pmRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSTransaction in Own Shares
21st Nov 20227:00 amRNSTransaction in Own Shares
18th Nov 20227:00 amRNSTransaction in Own Shares
17th Nov 20227:00 amRNSTransaction in Own Shares
16th Nov 20227:00 amRNSTransaction in Own Shares
15th Nov 202212:03 pmRNSDirector/PDMR Shareholding
15th Nov 20229:45 amRNSNotice of GM
15th Nov 20227:00 amRNSTransaction in Own Shares
11th Nov 20225:39 pmRNSTransaction in Own Shares
10th Nov 20226:20 pmRNSTransaction in Own Shares
10th Nov 20227:00 amRNSTransaction in Own Shares
9th Nov 20227:00 amRNSTransaction in Own Shares
8th Nov 20222:02 pmRNSDirector/PDMR Shareholding
8th Nov 20227:00 amRNSTransaction in Own Shares
7th Nov 20227:00 amRNSTransaction in Own Shares
3rd Nov 20225:56 pmRNSTransaction in Own Shares
3rd Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20227:00 amRNSTransaction in Own Shares
1st Nov 20222:24 pmRNSTotal Voting Rights
1st Nov 20227:00 amRNSTransaction in Own Shares
31st Oct 20227:00 amRNSTransaction in Own Shares
28th Oct 20227:00 amRNSTransaction in Own Shares
27th Oct 20227:00 amRNSTransaction in Own Shares
25th Oct 20226:19 pmRNSTransaction in Own Shares
24th Oct 20225:51 pmRNSTransaction in Own Shares
21st Oct 20226:12 pmRNSTransaction in Own Shares
21st Oct 20227:00 amRNSTransaction in Own Shares
20th Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20227:00 amRNSQ3 trading update
19th Oct 20227:00 amRNSStrategy for Sustainable Growth and new targets
18th Oct 20226:02 pmRNSTransaction in Own Shares
18th Oct 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.